Hormonal Therapy News and Research

RSS
Hormonal Therapy is treatment that adds, blocks, or removes hormones. For certain conditions (such as diabetes or menopause), hormones are given to adjust low hormone levels. To slow or stop the growth of certain cancers (such as prostate and breast cancer), synthetic hormones or other drugs may be given to block the body’s natural hormones. Sometimes surgery is needed to remove the gland that makes a certain hormone. Also called endocrine therapy, hormone therapy, and hormone treatment.
Soy useless for menopause

Soy useless for menopause

NanoString to begin clinical development program for Breast Cancer Intrinsic Subtyping Assay

NanoString to begin clinical development program for Breast Cancer Intrinsic Subtyping Assay

Hormone therapy may be hazardous in men with pre-existing heart conditions

Hormone therapy may be hazardous in men with pre-existing heart conditions

Late-stage prostate tumors are driven by different hormonal pathway

Late-stage prostate tumors are driven by different hormonal pathway

Flaxseed of no use in menopausal hot flashes: Study

Flaxseed of no use in menopausal hot flashes: Study

Androgen deprivation therapy may increase risk of diabetes in men with prostate cancer

Androgen deprivation therapy may increase risk of diabetes in men with prostate cancer

APC8015F investigational vaccine improves survival of prostate cancer patients

APC8015F investigational vaccine improves survival of prostate cancer patients

Providing complete information about breast cancer treatment options often ends up overwhelming patients

Providing complete information about breast cancer treatment options often ends up overwhelming patients

Study shows how specific nutritional combination may help maintain healthy breast tissue

Study shows how specific nutritional combination may help maintain healthy breast tissue

Estrogen only hormone replacement not so risky after 50’s: Study

Estrogen only hormone replacement not so risky after 50’s: Study

Prostate cancer updates

Prostate cancer updates

Breast cancer updates

Breast cancer updates

GHDX presents Oncotype DX breast cancer test study results at St. Gallen conference

GHDX presents Oncotype DX breast cancer test study results at St. Gallen conference

Hormonal therapy during menopause time may increase risk of breast cancer

Hormonal therapy during menopause time may increase risk of breast cancer

Sanofi-aventis announces publication of positive BSI-201 phase II results for breast cancer

Sanofi-aventis announces publication of positive BSI-201 phase II results for breast cancer

Men above age 75 with high-risk prostate cancer often under-treated

Men above age 75 with high-risk prostate cancer often under-treated

Genomic Health announces results of Oncotype DX test in early-stage breast cancer patients

Genomic Health announces results of Oncotype DX test in early-stage breast cancer patients

Everolimus plus tamoxifen delays disease progression in HR+/HER2- metastatic breast cancer

Everolimus plus tamoxifen delays disease progression in HR+/HER2- metastatic breast cancer

Clarient introduces Mammostrat test to quantify likelihood of breast cancer recurrence

Clarient introduces Mammostrat test to quantify likelihood of breast cancer recurrence

Zometa improves OS, PFS in newly diagnosed multiple myeloma patients: Phase III study

Zometa improves OS, PFS in newly diagnosed multiple myeloma patients: Phase III study

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.